Wolverine Trading
ADVM

Wolverine Trading’s Adverum Biotechnologies ADVM Stock Holding History

Wolverine Trading’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-25,100
Closed -$172K – 4708
2024
Q2 		$172K Buy
+25,100
New +$233K ﹤0.01% 3900
2023
Q4 		– Sell
-1,980
Closed -$29.7K – 4427
2023
Q3 		$29.7K Buy
+1,980
New +$35.5K ﹤0.01% 4268
2023
Q1 		– Sell
-1,440
Closed -$8K – 4137
2022
Q4 		$8K Buy
1,440
+80
+6% +$607 ﹤0.01% 3820
2022
Q3 		$13K Buy
1,360
+290
+27% +$3.81K ﹤0.01% 4420
2022
Q2 		$13K Sell
1,070
-270
-20% -$2.83K ﹤0.01% 4291
2022
Q1 		$18K Sell
1,340
-1,830
-58% -$26.8K ﹤0.01% 5255
2021
Q4 		$57K Sell
3,170
-310
-9% -$6.21K ﹤0.01% 5284
2021
Q3 		$77K Buy
3,480
+130
+4% +$3.32K ﹤0.01% 5892
2021
Q2 		$118K Buy
+3,350
New +$180K ﹤0.01% 5320

Other funds holding ADVM

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Wolverine Trading's ADVM Position: Q3 2023 in Review

Wolverine Trading sold out of Adverum Biotechnologies (ADVM) in Q3 2023, closing a stake of 1,326 shares — an estimated $23.8K sold.

Wolverine Trading first reported a position in ADVM in Q3 2022 and held it in 4 quarters. The position peaked at $21.1K in Q2 2023. 59 funds tracked by Wall St. Rank hold ADVM as of Q3 2023.

  • Wolverine Trading reported no remaining Adverum Biotechnologies position as of Q3 2023 after selling out during the quarter.
  • Wolverine Trading sold 1,326 Adverum Biotechnologies shares in Q3 2023, an estimated $23.8K.
  • Wolverine Trading first reported a position in Adverum Biotechnologies in Q3 2022 and held it in 4 quarters.
  • Wolverine Trading's Adverum Biotechnologies position peaked at $21.1K in Q2 2023.
  • 59 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q3 2023.

Based on Wolverine Trading's 13F filing for Q3 2023, filed 15 Nov 2023.